Basigin is a druggable target for hostoriented antimalarial interventions

Journal of Experimental Medicine

Volumn 212, Issue 8, 2015, Pages 1145-1151

  Zenonos, Zenon A ^a   Dummler, Sara K ^b   Müller Sienerth, Nicole ^a   Chen, Jianzhu ^b,d   Preiser, Peter R ^b,c   Rayner, Julian C ^a   Wright, Gavin J ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CD147 ANTIGEN; CHIMERIC ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AB 1; MONOCLONAL ANTIBODY MEM M6 6; PROTOZOAL PROTEIN; RECOMBINANT ANTIBODY; RH5 PROTEIN; UNCLASSIFIED DRUG; ANTIBODY; CARRIER PROTEIN; HYBRID PROTEIN; INTEGRATION HOST FACTOR; RH5 PROTEIN, PLASMODIUM FALCIPARUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIMALARIAL ACTIVITY; ARTICLE; CELL INVASION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG TARGETING; ERYTHROCYTE AGGREGATION; HUMAN; HUMAN CELL; INTERVENTION STUDY; MALARIA FALCIPARUM; MOUSE; NONHUMAN; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ANIMAL; DNA SEQUENCE; DRUG EFFECTS; ERYTHROCYTE; GENETICS; MALARIA; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PARASITOLOGY; SURFACE PLASMON RESONANCE;

ANIMALS; ANTIBODIES; ANTIGENS, CD147; BASE SEQUENCE; CARRIER PROTEINS; CLONING, MOLECULAR; ERYTHROCYTES; INTEGRATION HOST FACTORS; MALARIA; MICE; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; RECOMBINANT FUSION PROTEINS; SEQUENCE ANALYSIS, DNA; SURFACE PLASMON RESONANCE;

EID: 84941113488     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20150032     Document Type: Article

References (30)

1. Bruno, C.J., and J.M. Jacobson. 2010. Ibalizumab: an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection. J. Antimicrob. Chemother. 65:1839-1841. http://dx.doi.org/10.1093/jac/dkq261
2. Bushell, K.M., C. Söllner, B. Schuster-Boeckler, A. Bateman, and G.J. Wright. 2008. Large-scale screening for novel low-affinity extracellular protein interactions. Genome Res. 18:622-630. http://dx.doi.org/10.1101/gr.7187808
3. Chen, Z.-N., L. Mi, J. Xu, F. Song, Q. Zhang, Z. Zhang, J.-L. Xing, H.-J. Bian, J.-L. Jiang, X.-H. Wang, et al. 2006. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. Int. J. Radiat. Oncol. Biol. Phys. 65:435-444. http://dx.doi.org/10.1016/j.ijrobp.2005.12.034
4. Chen, L., S. Lopaticki, D.T. Riglar, C. Dekiwadia, A.D. Uboldi, W.-H. Tham, M.T. O'Neill, D. Richard, J. Baum, S.A. Ralph, and A.F. Cowman. 2011. An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum. PLoS Pathog. 7:e1002199. http://dx.doi.org/10.1371/journal.ppat.1002199
5. Chen, Q., A. Amaladoss, W. Ye, M. Liu, S. Dummler, F. Kong, L.H. Wong, H.L. Loo, E. Loh, S.Q. Tan, et al. 2014. Human natural killer cells control Plasmodium falciparum infection by eliminating infected red blood cells. Proc. Natl. Acad. Sci. USA. 111:1479-1484. http://dx.doi.org/10.1073/pnas.1323318111
6. Chiu, C.Y.H., J. Healer, J.K. Thompson, L. Chen, A. Kaul, L. Savergave, A. Raghuwanshi, C.S. Li Wai Suen, P.M. Siba, L. Schofield, et al. 2014. Association of antibodies to Plasmodium falciparum reticulocyte binding protein homolog 5 with protection from clinical malaria. Front Microbiol. 5:314. http://dx.doi.org/10.3389/fmicb.2014.00314
7. Crosnier, C., L.Y. Bustamante, S.J. Bartholdson, A.K. Bei, M. Theron, M. Uchikawa, S. Mboup, O. Ndir, D.P. Kwiatkowski, M.T. Duraisingh, et al. 2011. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature. 480:534-537. http://dx.doi.org/10.1038/nature10606
8. Deeg, H.J., B.R. Blazar, B.J. Bolwell, G.D. Long, F. Schuening, J. Cunningham, R.M. Rifkin, S. Abhyankar, A.D. Briggs, R. Burt, et al. 2001. Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL. Blood. 98:2052-2058. http://dx.doi.org/10.1182/blood. V98.7.2052
9. Douglas, A.D., A.R. Williams, E. Knuepfer, J.J. Illingworth, J.M. Furze, C. Crosnier, P. Choudhary, L.Y. Bustamante, S.E. Zakutansky, D.K. Awuah, et al. 2014. Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5. J. Immunol. 192:245-258. http://dx.doi.org/10.4049/jimmunol.1302045
10. Douglas, A.D., G.C. Baldeviano, C.M. Lucas, L.A. Lugo-Roman, C. Crosnier, S.J. Bartholdson, A. Diouf, K. Miura, L.E. Lambert, J.A. Ventocilla, et al. 2015. A PfRH5-based vaccine is efficacious against Heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys. Cell Host Microbe. 17:130-139. http://dx.doi.org/10.1016/j.chom.2014.11.017
11. Ghevaert, C., N. Herbert, L. Hawkins, N. Grehan, P. Cookson, S.F. Garner, A. Crisp-Hihn, P. Lloyd-Evans, A. Evans, K. Balan, et al. 2013. Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers. Blood. 122:313-320. http://dx.doi.org/10.1182/blood-2013-02-481887
12. Heslop, H.E., E. Benaim, M.K. Brenner, R.A. Krance, L.M. Stricklin, R.J. Rochester, and R. Billing. 1995. Response of steroid-resistant graftversus-host disease to lymphoblast antibody CBL1. Lancet. 346:805-806. http://dx.doi.org/10.1016/S0140-6736(95)91621-0
13. Hirsch, A.J., G.R. Medigeshi, H.L. Meyers, V. DeFilippis, K. Früh, T. Briese, W.I. Lipkin, and J.A. Nelson. 2005. The Src family kinase c-Yes is required for maturation of West Nile virus particles. J. Virol. 79:11943-11951. http://dx.doi.org/10.1128/JVI.79.18.11943-11951.2005
14. Jacobson, J.M., J.P. Lalezari, M.A. Thompson, C.J. Fichtenbaum, M.S. Saag, B.S. Zingman, P. D'Ambrosio, N. Stambler, Y. Rotshteyn, A.J. Marozsan, et al. 2010. Phase 2a study of the CCR5 monoclonal antibody PRO 140 administered intravenously to HIV-infected adults. Antimicrob. Agents Chemother. 54:4137-4142. http://dx.doi.org/10.1128/AAC.00086-10
15. Koch, C., G. Staffler, R. Hüttinger, I. Hilgert, E. Prager, J. Cernỳ, P. Steinlein, O. Majdic, V. Horejsí, and H. Stockinger. 1999. T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density. Int. Immunol. 11:777-786. http://dx.doi.org/10.1093/intimm/11.5.777
16. Lieberman-Blum, S.S., H.B. Fung, and J.C. Bandres. 2008. Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection. Clin. Ther. 30:1228-1250. http://dx.doi.org/10.1016/S0149-2918(08)80048-3
17. Macmillan, M.L., D. Couriel, D.J. Weisdorf, G. Schwab, N. Havrilla, T.R. Fleming, S. Huang, L. Roskos, S. Slavin, R.K. Shadduck, et al. 2007. A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versushost disease. Blood. 109:2657-2662. http://dx.doi.org/10.1182/blood-2006-08-013995
18. Morgan, A., N.D. Jones, A.M. Nesbitt, L. Chaplin, M.W. Bodmer, and J.S. Emtage. 1995. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding. Immunology. 86:319-324.
19. Morita, M., K. Kuba, A. Ichikawa, M. Nakayama, J. Katahira, R. Iwamoto, T. Watanebe, S. Sakabe, T. Daidoji, S. Nakamura, et al. 2013. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell. 153:112-125. http://dx.doi.org/10.1016/j.cell.2013.02.027
20. Ord, R.L., J.C. Caldeira, M. Rodriguez, A. Noe, B. Chackerian, D.S. Peabody, G. Gutierrez, and C.A. Lobo. 2014. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein. Malar. J. 13:326. http://dx.doi.org/10.1186/1475-2875-13-326
21. Prudêncio, M., and M.M. Mota. 2013. Targeting host factors to circumvent anti-malarial drug resistance. Curr. Pharm. Des. 19:290-299. http://dx.doi.org/10.2174/138161213804070276
22. Prussia, A., P. Thepchatri, J.P. Snyder, and R.K. Plemper. 2011. Systematic approaches towards the development of host-directed antiviral therapeutics. Int. J. Mol. Sci. 12:4027-4052. http://dx.doi.org/10.3390/ijms12064027
23. Qiu, X., G. Wong, J. Audet, A. Bello, L. Fernando, J.B. Alimonti, H. Fausther-Bovendo, H. Wei, J. Aviles, E. Hiatt, et al. 2014. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 514:47-53. http://dx.doi.org/10.1038/nature13777
24. Reddy, K.S., E. Amlabu, A.K. Pandey, P. Mitra, V.S. Chauhan, and D. Gaur. 2015. Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion. Proc. Natl. Acad. Sci. USA. 112:1179-1184. http://dx.doi.org/10.1073/pnas.1415466112
25. Reeves, P.M., B. Bommarius, S. Lebeis, S. McNulty, J. Christensen, A. Swimm, A. Chahroudi, R. Chavan, M.B. Feinberg, D. Veach, et al. 2005. Disabling poxvirus pathogenesis by inhibition of Ablfamily tyrosine kinases. Nat. Med. 11:731-739. http://dx.doi.org/10.1038/nm1265
26. Takahashi, H., H. Okazaki, P.I. Terasaki, Y. Iwaki, T. Kinukawa, Y. Taguchi, D. Chia, S. Hardiwidjaja, K. Miura, M. Ishizaki, et al. 1983. Reversal of transplant rejection by monoclonal antiblast antibody. Lancet. 2:1155-1158. http://dx.doi.org/10.1016/S0140-6736(83)91212-6
27. Tran, T.M., A. Ongoiba, J. Coursen, C. Crosnier, A. Diouf, C.Y. Huang, S. Li, S. Doumbo, D. Doumtabe, Y. Kone, et al. 2014. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria. J. Infect. Dis. 209:789-798. http://dx.doi.org/10.1093/infdis/jit553
28. Wanaguru, M., W. Liu, B.H. Hahn, J.C. Rayner, and G.J. Wright. 2013. RH5-Basigin interaction plays a major role in the host tropism of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 110:20735-20740. http://dx.doi.org/10.1073/pnas.1320771110
29. Wright, K.E., K.A. Hjerrild, J. Bartlett, A.D. Douglas, J. Jin, R.E. Brown, J.J. Illingworth, R. Ashfield, S.B. Clemmensen, W.A. de Jongh, et al. 2014. Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies. Nature. 515:427-430. http://dx.doi.org/10.1038/nature13715
30. Xu, J., Z.-Y. Shen, X.-G. Chen, Q. Zhang, H.-J. Bian, P. Zhu, H.-Y. Xu, F. Song, X.-M. Yang, L. Mi, et al. 2007. A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. Hepatology. 45:269-276. http://dx.doi.org/10.1002/hep.21465